Berbamine promotes macrophage autophagy to clear Mycobacterium tuberculosis by regulating the ROS/Ca 2+ axis
Open Access
- 29 June 2023
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 14 (4) , e0027223
Abstract
Drug-resistant tuberculosis (TB) poses a major threat to global TB control; consequently, there is an urgent need to develop novel anti-TB drugs or strategies. Host-directed therapy (HDT) is emerging as an effective treatment strategy, especially for drug-resistant TB. This study evaluated the effects of berbamine (BBM), a bisbenzylisoquinoline alkaloid, on mycobacterial growth in macrophages. BBM inhibited intracellular Mycobacterium tuberculosis (Mtb) growth by promoting autophagy and silencing ATG5, partially abolishing the inhibitory effect. In addition, BBM increased intracellular reactive oxygen species (ROS), while the antioxidant N -acetyl-L-cysteine (NAC) abolished BBM-induced autophagy and the ability to inhibit Mtb survival. Furthermore, the increased intracellular Ca 2+ concentration induced by BBM was regulated by ROS, and BAPTA-AM, an intracellular Ca 2+ -chelating agent, could block ROS-mediated autophagy and Mtb clearance. Finally, BBM could inhibit the survival of drug-resistant Mtb. Collectively, these findings provide evidence that BBM, a Food and Drug Administration (FDA)–approved drug, could effectively clear drug-sensitive and -resistant Mtb through regulating ROS/Ca 2+ axis-mediated autophagy and has potential as an HDT candidate for TB therapy. IMPORTANCE: It is urgent to develop novel treatment strategies against drug-resistant TB, and HDT provides a promising approach to fight drug-resistant TB by repurposing old drugs. Our studies demonstrate, for the first time, that BBM, an FDA-approved drug, not only potently inhibits intracellular drug-sensitive Mtb growth but also restricts drug-resistant Mtb by promoting macrophage autophagy. Mechanistically, BBM activates macrophage autophagy by regulating the ROS/Ca 2+ axis. In conclusion, BBM could be considered as an HDT candidate and may contribute to improving the outcomes or shortening the treatment course of drug-resistant TB.Keywords
Funding Information
- National Key Researsh and Development Plan (2021YFA1300902)
- MOST | National Natural Science Foundation of China (82170009)
- MOST | National Natural Science Foundation of China (82100013)
- Guangdong Scientific and Technological Foundation (2019B1515120041)
- Guangdong Scientific and Technological Foundation (2020B1111170014)
- Guangxi Scientific and Technological Foundation (AA22096027)
- Shenzhen Scientific and Technological Foundation (KCXFZ20211020163545004)
- Shenzhen Scientific and Technological Foundation (KCXFZ202002011007083)
- Shenzhen Scientific and Technological Foundation (JCYJ20190809104205706)
This publication has 33 references indexed in Scilit:
- Current knowledge and pharmacological profile of berberine: An updateEuropean Journal of Pharmacology, 2015
- A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signalingCancer Biology & Therapy, 2013
- CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamineBlood, 2012
- Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine, 2012
- A dual role for Ca2+ in autophagy regulationCell Calcium, 2011
- Effect of proteinS-glutathionylation on Ca2+homeostasis in cultured aortic endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Alisol B, a Novel Inhibitor of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Pump, Induces Autophagy, Endoplasmic Reticulum Stress, and ApoptosisMolecular Cancer Therapeutics, 2010
- The many niches and strategies used by pathogenic mycobacteria for survival within host macrophagesImmunobiology, 2009
- Activation of antibacterial autophagy by NADPH oxidasesProceedings of the National Academy of Sciences, 2009
- LC3 and Autophagy2008